Latest Translational Drug Development Stories
The new TRC-TD2 partnership will allow investigators the ability to test the efficacy of new radiation techniques with potential new drugs. SCOTTSDALE, Ariz. (PRWEB) June 21, 2013 Cancer pharmaceutical development company, Translational Drug Development (TD2), and the Translational Research Consortium (TRC) today announced a new partnership to enable rapid testing of anti-cancer drugs combined with radiation therapy. The new TRC-TD2 partnership will allow investigators the ability to test...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.